Excel Diagnostics and Nuclear Oncology Center   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Houston TX United States (2003)

Organization Overview

First Clinical Trial
2010
NCT01237457
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Excel Diagnostics and Nuclear Oncology Center | Excel Diagnostics and Nuclear Oncology Clinic